Cambridge Investment Research Advisors
MSOS icon

Cambridge Investment Research Advisors’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Cambridge Investment Research Advisors’s Portfolio MSOS Stock Details MSOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Buy
53,209
+25,439
+92% +$119K ﹤0.01% 3541
2026
Q1 		$99K Buy
27,770
+81
+0.3% +$332 ﹤0.01% 3795
2025
Q4 		$131K Buy
27,689
+2,226
+9% +$9.92K ﹤0.01% 3659
2025
Q3 		$122K Sell
25,463
-4,215
-14% -$16.6K ﹤0.01% 3576
2025
Q2 		$72K Sell
29,678
-4,083
-12% -$10K ﹤0.01% 3509
2025
Q1 		$88K Sell
33,761
-5,823
-15% -$18.8K ﹤0.01% 3367
2024
Q4 		$151K Sell
39,584
-4,327
-10% -$23.3K ﹤0.01% 3252
2024
Q3 		$315K Buy
43,911
+4,250
+11% +$30.2K ﹤0.01% 2797
2024
Q2 		$291K Sell
39,661
-83
-0.2% -$724 ﹤0.01% 2727
2024
Q1 		$398K Buy
39,744
+11,366
+40% +$99.5K ﹤0.01% 2475
2023
Q4 		$199K Sell
28,378
-21,902
-44% -$146K ﹤0.01% 2909
2023
Q3 		$399K Buy
50,280
+5,025
+11% +$31.7K ﹤0.01% 2271
2023
Q2 		$251K Sell
45,255
-9,162
-17% -$50.2K ﹤0.01% 2687
2023
Q1 		$310K Sell
54,417
-26,884
-33% -$178K ﹤0.01% 2462
2022
Q4 		$568K Sell
81,301
-40,753
-33% -$419K ﹤0.01% 1916
2022
Q3 		$1.09M Buy
122,054
+13,911
+13% +$161K 0.01% 1417
2022
Q2 		$1.12M Sell
108,143
-4,573
-4% -$67.9K 0.01% 1404
2022
Q1 		$2.35M Sell
112,716
-24,391
-18% -$532K 0.01% 1041
2021
Q4 		$3.51M Sell
137,107
-24,556
-15% -$678K 0.02% 831
2021
Q3 		$5.1M Buy
161,663
+29,157
+22% +$1.01M 0.03% 599
2021
Q2 		$5.3M Sell
132,506
-65,125
-33% -$2.65M 0.03% 589
2021
Q1 		$8.38M Buy
197,631
+55,407
+39% +$2.56M 0.05% 382
2020
Q4 		$5.19M Buy
+142,224
New +$4.24M 0.03% 515

Other funds holding MSOS

AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
MG
Marex Group London $23.6B AUM 57.16% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
M
Murchinson Toronto, Ontario, Canada $725M AUM 82.02% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return

Cambridge Investment Research Advisors's MSOS Position: Q2 2026 in Review

Cambridge Investment Research Advisors increased its AdvisorShares Pure US Cannabis ETF (MSOS) stake by 92% in Q2 2026, buying an estimated $119K and bringing the position to 53,209 shares worth $270K. The position accounts for ﹤0.01% of the portfolio, ranked #3541.

Cambridge Investment Research Advisors first reported a position in MSOS in Q4 2020 and has held it in 23 quarters since. The position peaked at $8.38M in Q1 2021. 169 funds tracked by Wall St. Rank hold MSOS as of Q2 2026.

  • Cambridge Investment Research Advisors held 53,209 shares of AdvisorShares Pure US Cannabis ETF worth $270K as of Q2 2026.
  • Cambridge Investment Research Advisors bought 25,439 AdvisorShares Pure US Cannabis ETF shares in Q2 2026, an estimated $119K.
  • AdvisorShares Pure US Cannabis ETF made up ﹤0.01% of Cambridge Investment Research Advisors's portfolio in Q2 2026, its #3541 holding.
  • Cambridge Investment Research Advisors first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2020 and has held it in 23 quarters since.
  • Cambridge Investment Research Advisors's AdvisorShares Pure US Cannabis ETF position peaked at $8.38M in Q1 2021.
  • 169 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q2 2026.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.